Last reviewed · How we verify

1% Buffered Lidocaine 1:100,000 Epinephrine

University of North Carolina, Chapel Hill · FDA-approved active Small molecule Quality 2/100

1% Buffered Lidocaine 1:100,000 Epinephrine is a Small molecule drug developed by University of North Carolina, Chapel Hill. It is currently FDA-approved. Also known as: Xylocaine.

At a glance

Generic name1% Buffered Lidocaine 1:100,000 Epinephrine
Also known asXylocaine
SponsorUniversity of North Carolina, Chapel Hill
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about 1% Buffered Lidocaine 1:100,000 Epinephrine

What is 1% Buffered Lidocaine 1:100,000 Epinephrine?

1% Buffered Lidocaine 1:100,000 Epinephrine is a Small molecule drug developed by University of North Carolina, Chapel Hill.

Who makes 1% Buffered Lidocaine 1:100,000 Epinephrine?

1% Buffered Lidocaine 1:100,000 Epinephrine is developed and marketed by University of North Carolina, Chapel Hill (see full University of North Carolina, Chapel Hill pipeline at /company/university-of-north-carolina-chapel-hill).

Is 1% Buffered Lidocaine 1:100,000 Epinephrine also known as anything else?

1% Buffered Lidocaine 1:100,000 Epinephrine is also known as Xylocaine.

What development phase is 1% Buffered Lidocaine 1:100,000 Epinephrine in?

1% Buffered Lidocaine 1:100,000 Epinephrine is FDA-approved (marketed).

Related